Becton, Dickinson and Company logo

Becton, Dickinson and Company (BDX)

Market Open
3 Mar, 20:37
NYSE NYSE
$
174. 55
-1.99
-1.13%
$
63.94B Market Cap
- P/E Ratio
3.8% Div Yield
1,172,872 Volume
- Eps
$ 176.54
Previous Close
Day Range
171.57 174.99
Year Range
127.59 187.35
Want to track BDX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
BDX earnings report is expected in 57 days (29 Apr 2026)
BDX Stock Down Despite New Expansion to Boost Fingertip Blood Testing

BDX Stock Down Despite New Expansion to Boost Fingertip Blood Testing

The blood testing process integrating BD's MiniDraw System with Babson's BetterWay technologies is likely to lower common barriers to testing and improve patient outcomes.

Zacks | 1 year ago
Here's Why Becton Dickinson (BDX) is a Strong Value Stock

Here's Why Becton Dickinson (BDX) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 year ago
Why Becton Dickinson (BDX) is a Top Momentum Stock for the Long-Term

Why Becton Dickinson (BDX) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 year ago
Becton Dickinson settles charges over infusion pump risks, SEC says

Becton Dickinson settles charges over infusion pump risks, SEC says

The U.S. Securities and Exchange Commission said on Monday that it had settled charges with Becton Dickinson and Co. over allegations it misled investors about risks associated with its Alaris infusion pump.

Reuters | 1 year ago
4 Stocks to Watch Amid Dental Supplies Industry Challenges

4 Stocks to Watch Amid Dental Supplies Industry Challenges

Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These are BDX, MCK, CAH and MMSI.

Zacks | 1 year ago
Santa's Stunning Stocking Surprises: 5 High Yield Blue-Chip Bargains For 2025

Santa's Stunning Stocking Surprises: 5 High Yield Blue-Chip Bargains For 2025

Investing in blue-chip stocks at 52-week lows can potentially yield significant returns if fundamentals are strong. Avoid value traps by focusing on companies with solid fundamentals, like Elevance Health, Becton, Dickinson, LyondellBasell, Rogers Communications and Rexford Industrial Realty. These companies offer a 3.7% yield and a 27% discount to fair value, and they have historically outperformed the market with 27% less volatility.

Seekingalpha | 1 year ago
12 High-Yield Dividend Aristocrats To Weather The Coming 2025 Storm In Style

12 High-Yield Dividend Aristocrats To Weather The Coming 2025 Storm In Style

The S&P is up almost 28% in 2024, and many investors worry about a melt-up followed by a sharp correction like in 2022 or 2018. A 2025 market correction is likely, but low-volatility, high-yield Dividend Aristocrats offer a better alternative to the traditional 60-40 portfolio and S&P. These 12 Aristocrats provide a 3.2% yield, 14% discount, 22% upside potential next year, and 10% long-term income growth consensus, while being 54% lower volatility than the S&P.

Seekingalpha | 1 year ago
These 5 Stocks Have 50 Years of Dividend Growth—Here's How to Find More

These 5 Stocks Have 50 Years of Dividend Growth—Here's How to Find More

With a new presidential administration set to take office on Jan. 20, 2025, some investors may be uncertain about how new policies and personnel will affect the stock market and interest rates. Will tariffs, discarded trade deals, and frayed alliances help or hurt the market?

Investopedia | 1 year ago
Becton, Dickinson and Company (BDX) 7th Annual Evercore ISI HealthCONx Conference (Transcript)

Becton, Dickinson and Company (BDX) 7th Annual Evercore ISI HealthCONx Conference (Transcript)

Becton, Dickinson and Company (NYSE:BDX ) 7th Annual Evercore ISI HealthCONx Results Conference December 3, 2024 10:50 AM ET Company Participants Richard Byrd - EVP and President of Interventional Business Chris DelOrefice - Executive Vice President & Chief Financial Officer Conference Call Participants Vijay Kumar - Evercore ISI Vijay Kumar Thanks, everyone, for joining us this morning. A pleasure to have with us Becton, Dickinson.

Seekingalpha | 1 year ago
Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term

Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 year ago
Becton, Dickinson and Company Q4: Shifting To High-Growth Areas

Becton, Dickinson and Company Q4: Shifting To High-Growth Areas

Becton, Dickinson and Company is projected to achieve 8.8%-9.3% revenue growth in FY25, driven by new product launches and the APM business. The acquisition of Edwards Lifesciences' Critical Care product group is expected to significantly boost BD's Advanced Patient Monitoring segment. BD plans to reduce debt leverage to 2.5x and repurchase $1 billion in shares, enhancing financial stability and shareholder value.

Seekingalpha | 1 year ago
Are Investors Undervaluing Becton, Dickinson and Company (BDX) Right Now?

Are Investors Undervaluing Becton, Dickinson and Company (BDX) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 year ago
Loading...
Load More